Mirum Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing treatments for rare diseases, particularly those affecting children. The company has three approved medications: LIVMARLI® (maralixibat) for cholestatic pruritus in Alagille syndrome and progressive familial intrahepatic cholestasis (PFIC), CHOLBAM® (cholic acid) for bile acid synthesis disorders, and CTEXLI™ (chenodiol) for cerebrotendinous xanthomatosis. Mirum is also advancing a pipeline of investigational treatments, including Volixibat for primary sclerosing cholangitis and Fragile X syndrome, showcasing its commitment to innovative solutions in rare disease therapy.
Mirum Pharmaceuticals is seeking a Field Medical Manager (FMM) to act as a scientific expert within their Medical Affairs organization. The role involves building and maintaining relationships with healthcare professionals and key opinion leaders, contributing to regional medical strategy, and serving as a liaison between researchers and investigators. The position requires a strong understanding of scientific communication and a passion for advancing scientific discoveries in rare diseases.
Mirum Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing treatments for rare diseases, particularly those affecting children. The company has three approved medications: LIVMARLI® (maralixibat) for cholestatic pruritus in Alagille syndrome and progressive familial intrahepatic cholestasis (PFIC), CHOLBAM® (cholic acid) for bile acid synthesis disorders, and CTEXLI™ (chenodiol) for cerebrotendinous xanthomatosis. Mirum is also advancing a pipeline of investigational treatments, including Volixibat for primary sclerosing cholangitis and Fragile X syndrome, showcasing its commitment to innovative solutions in rare disease therapy.